126 related articles for article (PubMed ID: 17418809)
1. Inhibition of breast cancer cell adhesion and bone metastasis by the extracellular adherence protein of Staphylococcus aureus.
Schneider D; Liaw L; Daniel C; Athanasopoulos AN; Herrmann M; Preissner KT; Nawroth PP; Chavakis T
Biochem Biophys Res Commun; 2007 May; 357(1):282-8. PubMed ID: 17418809
[TBL] [Abstract][Full Text] [Related]
2. A small molecule antagonist of the alpha(v)beta3 integrin suppresses MDA-MB-435 skeletal metastasis.
Harms JF; Welch DR; Samant RS; Shevde LA; Miele ME; Babu GR; Goldberg SF; Gilman VR; Sosnowski DM; Campo DA; Gay CV; Budgeon LR; Mercer R; Jewell J; Mastro AM; Donahue HJ; Erin N; Debies MT; Meehan WJ; Jones AL; Mbalaviele G; Nickols A; Christensen ND; Melly R; Beck LN; Kent J; Rader RK; Kotyk JJ; Pagel MD; Westlin WF; Griggs DW
Clin Exp Metastasis; 2004; 21(2):119-28. PubMed ID: 15168729
[TBL] [Abstract][Full Text] [Related]
3. Bone sialoprotein supports breast cancer cell adhesion proliferation and migration through differential usage of the alpha(v)beta3 and alpha(v)beta5 integrins.
Sung V; Stubbs JT; Fisher L; Aaron AD; Thompson EW
J Cell Physiol; 1998 Sep; 176(3):482-94. PubMed ID: 9699501
[TBL] [Abstract][Full Text] [Related]
4. Expression and characterization of recombinant osteopontin peptides representing matrix metalloproteinase proteolytic fragments.
Gao YA; Agnihotri R; Vary CP; Liaw L
Matrix Biol; 2004 Nov; 23(7):457-66. PubMed ID: 15579312
[TBL] [Abstract][Full Text] [Related]
5. Adhesion and migration of extracellular matrix-stimulated breast cancer.
Bartsch JE; Staren ED; Appert HE
J Surg Res; 2003 Mar; 110(1):287-94. PubMed ID: 12697413
[TBL] [Abstract][Full Text] [Related]
6. Osteopontin knockdown inhibits αv,β3 integrin-induced cell migration and invasion and promotes apoptosis of breast cancer cells by inducing autophagy and inactivating the PI3K/Akt/mTOR pathway.
Zhang H; Guo M; Chen JH; Wang Z; Du XF; Liu PX; Li WH
Cell Physiol Biochem; 2014; 33(4):991-1002. PubMed ID: 24714122
[TBL] [Abstract][Full Text] [Related]
7. Beta(3) integrin expression increases breast carcinoma cell responsiveness to the malignancy-enhancing effects of osteopontin.
Furger KA; Allan AL; Wilson SM; Hota C; Vantyghem SA; Postenka CO; Al-Katib W; Chambers AF; Tuck AB
Mol Cancer Res; 2003 Sep; 1(11):810-9. PubMed ID: 14517343
[TBL] [Abstract][Full Text] [Related]
8. The relationship between bone metastasis from human breast cancer and integrin alpha(v)beta3 expression.
Takayama S; Ishii S; Ikeda T; Masamura S; Doi M; Kitajima M
Anticancer Res; 2005; 25(1A):79-83. PubMed ID: 15816522
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of tumor formation by snake venom disintegrin.
Yang RS; Tang CH; Chuang WJ; Huang TH; Peng HC; Huang TF; Fu WM
Toxicon; 2005 Apr; 45(5):661-9. PubMed ID: 15777962
[TBL] [Abstract][Full Text] [Related]
10. Integrin alpha(v)beta3 expression confers on tumor cells a greater propensity to metastasize to bone.
Pécheur I; Peyruchaud O; Serre CM; Guglielmi J; Voland C; Bourre F; Margue C; Cohen-Solal M; Buffet A; Kieffer N; Clézardin P
FASEB J; 2002 Aug; 16(10):1266-8. PubMed ID: 12153995
[TBL] [Abstract][Full Text] [Related]
11. Bone sialoprotein, matrix metalloproteinase 2, and alpha(v)beta3 integrin in osteotropic cancer cell invasion.
Karadag A; Ogbureke KU; Fedarko NS; Fisher LW
J Natl Cancer Inst; 2004 Jun; 96(12):956-65. PubMed ID: 15199115
[TBL] [Abstract][Full Text] [Related]
12. RNA aptamer blockade of osteopontin inhibits growth and metastasis of MDA-MB231 breast cancer cells.
Mi Z; Guo H; Russell MB; Liu Y; Sullenger BA; Kuo PC
Mol Ther; 2009 Jan; 17(1):153-61. PubMed ID: 18985031
[TBL] [Abstract][Full Text] [Related]
13. The thrombin inhibitor Argatroban reduces breast cancer malignancy and metastasis via osteopontin-dependent and osteopontin-independent mechanisms.
Schulze EB; Hedley BD; Goodale D; Postenka CO; Al-Katib W; Tuck AB; Chambers AF; Allan AL
Breast Cancer Res Treat; 2008 Nov; 112(2):243-54. PubMed ID: 18097747
[TBL] [Abstract][Full Text] [Related]
14. The extracellular adherence protein (Eap) of Staphylococcus aureus acts as a proliferation and migration repressing factor that alters the cell morphology of keratinocytes.
Eisenbeis J; Peisker H; Backes CS; Bur S; Hölters S; Thewes N; Greiner M; Junker C; Schwarz EC; Hoth M; Junker K; Preissner KT; Jacobs K; Herrmann M; Bischoff M
Int J Med Microbiol; 2017 Feb; 307(2):116-125. PubMed ID: 28117265
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of Cellular Adhesion by Immunological Targeting of Osteopontin Neoepitopes Generated through Matrix Metalloproteinase and Thrombin Cleavage.
Jürets A; Le Bras M; Staffler G; Stein G; Leitner L; Neuhofer A; Tardelli M; Turkof E; Zeyda M; Stulnig TM
PLoS One; 2016; 11(2):e0148333. PubMed ID: 26840958
[TBL] [Abstract][Full Text] [Related]
16. The LCC15-MB human breast cancer cell line expresses osteopontin and exhibits an invasive and metastatic phenotype.
Sung V; Gilles C; Murray A; Clarke R; Aaron AD; Azumi N; Thompson EW
Exp Cell Res; 1998 Jun; 241(2):273-84. PubMed ID: 9637769
[TBL] [Abstract][Full Text] [Related]
17. Role of the integrin-binding protein osteopontin in lymphatic metastasis of breast cancer.
Allan AL; George R; Vantyghem SA; Lee MW; Hodgson NC; Engel CJ; Holliday RL; Girvan DP; Scott LA; Postenka CO; Al-Katib W; Stitt LW; Uede T; Chambers AF; Tuck AB
Am J Pathol; 2006 Jul; 169(1):233-46. PubMed ID: 16816376
[TBL] [Abstract][Full Text] [Related]
18. Alpha-V-dependent outside-in signaling is required for the regulation of CD44 surface expression, MMP-2 secretion, and cell migration by osteopontin in human melanoma cells.
Samanna V; Wei H; Ego-Osuala D; Chellaiah MA
Exp Cell Res; 2006 Jul; 312(12):2214-30. PubMed ID: 16631740
[TBL] [Abstract][Full Text] [Related]
19. Osteopontin is highly susceptible to cleavage in bovine milk and the proteolytic fragments bind the αVβ₃-integrin receptor.
Christensen B; Sørensen ES
J Dairy Sci; 2014; 97(1):136-46. PubMed ID: 24268404
[TBL] [Abstract][Full Text] [Related]
20. Activation of JAK2/STAT3 signaling by osteopontin promotes tumor growth in human breast cancer cells.
Behera R; Kumar V; Lohite K; Karnik S; Kundu GC
Carcinogenesis; 2010 Feb; 31(2):192-200. PubMed ID: 19926637
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]